CCL5 and liver cancer: However, normal cells infected with SG511-CCL5-ODD showed a >50% cell viability at an MOI of 10 pfu/cell, suggesting that >10–100-fold of SG511-CCL5-ODD were needed to kill half of the normal fibroblast cells compared with liver cancer cells (Fig. 2).